Pill to treat pancreatic cancer hailed as 'biggest breakthrough in decades' (theguardian.com)

52 points by rafaelc a day ago

mft_ 19 minutes ago

For once, this isn’t hyperbole. Metastatic pancreatic cancer hasn’t had a meaningful new treatment in literally decades - it’s been brutal chemotherapy or slightly less brutal chemotherapy.

The new generation of KRAS inhibitors, of which daraxonrasib is just the first to make it to approval, is genuinely a practice-changing breakthrough.

It won’t cure people with metastatic disease, but it will help a lot live better lives for longer.

233mhz 14 minutes ago

> For once, this isn’t hyperbole.

Am I missing something?

From other sources:

> Median overall survival: 13.2 months versus about 6.6 to 6.7 months with chemotherapy.

scarmig 11 minutes ago

Doubling life expectancy on a form of cancer infamous as a death sentence.

shevy-java 2 minutes ago

tedggh 7 minutes ago

Everything is relative. A few more months of life with less pain and more energy to spend it with family surely is a breakthrough for many patients and for the doctors treating them.

shevy-java a minute ago

dang 26 minutes ago

In case others are wondering, it looks like this is a different story than this recent one:

Pancreatic cancer halted by virus injection in three patients - https://news.ycombinator.com/item?id=50563066 - Nov 2026 (157 comments)